Literature DB >> 11391746

Comorbidity of the nonmotor symptoms of Parkinson's disease.

L M Shulman1, R L Taback, J Bean, W J Weiner.   

Abstract

Many patients with Parkinson's disease (PD) have clinically significant anxiety, depression, fatigue, sleep disturbance, or sensory symptoms. The comorbidity of these nonmotor symptoms and their relationship to PD severity has not been extensively evaluated. Ninety- nine nondemented PD patients were evaluated with the following battery of tests: Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Fatigue Severity Scale (FSS), Pittsburgh Sleep Quality Index (PSQI), a sensory symptom questionnaire, Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn & Yahr (H/Y) Stage, and the Schwab & England ADL scale (S/E). The comorbidity of the nonmotor symptoms and their relationship to PD severity was analyzed. Thirty-six percent of the study population had depression (BDI > or =10), 33% had anxiety (BAI > or =10), 40% had fatigue (FSS > 4), 47% had sleep disturbance (PSQI > 5), and 63% reported sensory symptoms. Only 12% of the sample had no nonmotor symptoms. Fifty-nine percent of the patients had two or more nonmotor symptoms, and nearly 25% had four or more. Increased comorbidity was associated with greater PD severity (P < 001). This study reveals that the nonmotor symptoms of PD frequently occur together in the same patients. Increased comorbidity of the five nonmotor symptoms was associated with greater PD severity. These results suggest that recognition of these diverse nonmotor symptoms may be enhanced by looking for others when one nonmotor symptom has been identified. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Year:  2001        PMID: 11391746     DOI: 10.1002/mds.1099

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  90 in total

1.  The development and testing of an instrument for perceived self-efficacy for fatigue self-management.

Authors:  Amy J Hoffman; Alexander von Eye; Audrey G Gift; Barbara A Given; Charles W Given; Marilyn Rothert
Journal:  Cancer Nurs       Date:  2011 May-Jun       Impact factor: 2.592

Review 2.  Neuropsychiatric non-motor aspects of Parkinson's disease.

Authors:  B R Thanvi; S K Munshi; N Vijaykumar; T C N Lo
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

Review 3.  Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Authors:  J M Pavon; H E Whitson; M S Okun
Journal:  Maturitas       Date:  2010-02-01       Impact factor: 4.342

4.  Neuroimaging and clinical predictors of fatigue in Parkinson disease.

Authors:  Kelvin L Chou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Parkinsonism Relat Disord       Date:  2015-12-02       Impact factor: 4.891

5.  Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

Authors:  Giovanni Schifitto; Lijuan Deng; Tzu-Min Yeh; Scott R Evans; Thomas Ernst; Jianhui Zhong; David Clifford
Journal:  J Neurovirol       Date:  2010-12-23       Impact factor: 2.643

6.  Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease.

Authors:  T J Loher; J-M Burgunder; S Weber; R Sommerhalder; J K Krauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

7.  Depression in Parkinson's disease. Diffusion tensor imaging study.

Authors:  Hideaki Matsui; Kazuto Nishinaka; Masaya Oda; Hidekazu Niikawa; Kenichi Komatsu; Tamotsu Kubori; Fukashi Udaka
Journal:  J Neurol       Date:  2006-08-20       Impact factor: 4.849

Review 8.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

9.  Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine.

Authors:  Eric H Chudler; Ying Lu
Journal:  Brain Res       Date:  2008-04-08       Impact factor: 3.252

10.  Laryngeal somatosensory deficits in Parkinson's disease: implications for speech respiratory and phonatory control.

Authors:  Michael J Hammer; Steven M Barlow
Journal:  Exp Brain Res       Date:  2009-12-15       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.